In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1832 News Items found
MSK medical oncologist and bladder cancer specialist Jonathan Rosenberg
Bladder Cancer Therapy Enfortumab Vedotin (Padcev) Approved by FDA for More Patients

A powerful therapy called an antibody-drug conjugate has been approved by the FDA for more people with bladder cancer.
Article
MSK medical oncologist and breast cancer specialist Dr. Komal Jhaveri.
Antibody-Drug Conjugate for Endocrine-Refractory and Chemotherapy Naive HR+, HER2- Breast Cancer

Read about an antibody-drug conjugate treatment for HR+, HER2- breast cancer.
MSK multiple myeloma specialist Urvy Shah
Diets for MGUS, Smoldering Myeloma, and Multiple Myeloma: Q&A With MSK Cancer and Nutrition Experts

Learn how eating a plant-based diet may prevent MGUS and smoldering myeloma from developing into multiple myeloma, according to MSK research.
Dr. Urvi Shah is seen smiling at the camera.
MSK Research Reveals Connection Between Diet and Cancer

Learn more about how a clinical trial at MSK revealed important connections between the foods we eat and our cancer risk.
Clinical Update
MSK cellular therapist Heather Landau
CAR T Cell Therapy for Light Chain (AL) Amyloidosis Achieves Strong Results

Read about a CAR T cell therapy that appears effective against light chain (AL) amyloidosis.
Article
MSK myeloma specialist and cellular therapist Saad Usmani, MD
New Extramedullary Myeloma Treatment With Bispecific Antibodies Improves Survival Dramatically

Read about a new treatment combining bispecific antibodies that is effective against extramedullary myeloma.
Michael with his granddaughter on a boat
New Treatment for Relapsed Follicular Lymphoma Approved by FDA After MSK-Led Clinical Trial

A phase 3 trial led by MSK showed that adding epcoritamab to traditional treatment for follicular lymphoma benefits patients. Epcoritamab received FDA approval based on the findings.
MSK breast cancer patient Majiel Baker is seen at the beach with her husband and children.
Cancer Care Worth Traveling For: Why People Come to MSK From Across the Country

Learn why over 5,000 people a year travel more than 150 miles to MSK for cancer care, including resources for the specific needs of traveling patients and their loved ones.
Breast medical oncologist Sherry Shen is seen smiling outdoors.
Cancer Benefits and Risks From Ozempic, Wegovy, and Other Weight Loss Drugs

Learn what Zepbound, Wegovy, Ozempic and other weight loss drugs mean for cancer risk and treatment, from an expert at MSK.
Q&A
Dr. Omar Abdel-Wahab in his lab
Meet Omar Abdel-Wahab: A 2025 Paul Marks Prize Recipient 

A leader in developing better treatments for a range of blood cancers, Dr. Omar Abdel-Wahab is only the second person from MSK to receive the Paul Marks Prize for Cancer Research.